113 related articles for article (PubMed ID: 23069914)
1. Lyophilisomes as a new generation of drug delivery capsules.
van Bracht E; Raavé R; Verdurmen WP; Wismans RG; Geutjes PJ; Brock RE; Oosterwijk E; van Kuppevelt TH; Daamen WF
Int J Pharm; 2012 Dec; 439(1-2):127-35. PubMed ID: 23069914
[TBL] [Abstract][Full Text] [Related]
2. Specific targeting of tumor cells by lyophilisomes functionalized with antibodies.
van Bracht E; Stolle S; Hafmans TG; Boerman OC; Oosterwijk E; van Kuppevelt TH; Daamen WF
Eur J Pharm Biopharm; 2014 May; 87(1):80-9. PubMed ID: 24463217
[TBL] [Abstract][Full Text] [Related]
3. Enhanced cellular uptake of albumin-based lyophilisomes when functionalized with cell-penetrating peptide TAT in HeLa cells.
van Bracht E; Versteegden LR; Stolle S; Verdurmen WP; Woestenenk R; Raavé R; Hafmans T; Oosterwijk E; Brock R; van Kuppevelt TH; Daamen WF
PLoS One; 2014; 9(11):e110813. PubMed ID: 25369131
[TBL] [Abstract][Full Text] [Related]
4. Graphene-based anticancer nanosystem and its biosafety evaluation using a zebrafish model.
Liu CW; Xiong F; Jia HZ; Wang XL; Cheng H; Sun YH; Zhang XZ; Zhuo RX; Feng J
Biomacromolecules; 2013 Feb; 14(2):358-66. PubMed ID: 23286342
[TBL] [Abstract][Full Text] [Related]
5. Formulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy.
Mukerjee A; Vishwanatha JK
Anticancer Res; 2009 Oct; 29(10):3867-75. PubMed ID: 19846921
[TBL] [Abstract][Full Text] [Related]
6. Nano-sized albumin-copolymer micelles for efficient doxorubicin delivery.
Wu Y; Shih EK; Ramanathan A; Vasudevan S; Weil T
Biointerphases; 2012 Dec; 7(1-4):5. PubMed ID: 22589048
[TBL] [Abstract][Full Text] [Related]
7. Biodistribution of size-selected lyophilisomes in mice.
van Bracht E; Raavé R; Perevyazko IY; Versteeg EM; Hafmans TG; Schubert US; Oosterwijk E; van Kuppevelt TH; Daamen WF
Eur J Pharm Biopharm; 2015 Aug; 94():141-51. PubMed ID: 25953331
[TBL] [Abstract][Full Text] [Related]
8. Lyophilisomes: Potential carriers for tumor targeting.
van Bracht E; Geutjes PJ; Woestenenk R; Wismans RG; Oosterwijk E; van Kuppevelt TH; Daamen WF
J Control Release; 2010 Nov; 148(1):e7-8. PubMed ID: 21529636
[No Abstract] [Full Text] [Related]
9. Polymeric micellar co-delivery of resveratrol and curcumin to mitigate in vitro doxorubicin-induced cardiotoxicity.
Carlson LJ; Cote B; Alani AW; Rao DA
J Pharm Sci; 2014 Aug; 103(8):2315-22. PubMed ID: 24914015
[TBL] [Abstract][Full Text] [Related]
10. Synergistic anti-cancer effects via co-delivery of TNF-related apoptosis-inducing ligand (TRAIL/Apo2L) and doxorubicin using micellar nanoparticles.
Lee AL; Dhillon SH; Wang Y; Pervaiz S; Fan W; Yang YY
Mol Biosyst; 2011 May; 7(5):1512-22. PubMed ID: 21350763
[TBL] [Abstract][Full Text] [Related]
11. Block co-polymer nanoparticles with degradable cross-linked core and low-molecular-weight PEG corona for anti-tumour drug delivery.
Abraham G; McCarroll J; Byrne F; Saricilar S; Kavallaris M; Bulmus V
J Biomater Sci Polym Ed; 2011; 22(8):1001-22. PubMed ID: 20566070
[TBL] [Abstract][Full Text] [Related]
12. Functional Albumin Nanoformulations to Fight Adrenocortical Carcinoma: a Redox-Responsive Approach.
Curcio M; Avena P; Cirillo G; Casaburi I; Spizzirri UG; Nicoletta FP; Iemma F; Pezzi V
Pharm Res; 2020 Feb; 37(3):55. PubMed ID: 32060727
[TBL] [Abstract][Full Text] [Related]
13. Curcumin-loaded biodegradable polymeric micelles for colon cancer therapy in vitro and in vivo.
Gou M; Men K; Shi H; Xiang M; Zhang J; Song J; Long J; Wan Y; Luo F; Zhao X; Qian Z
Nanoscale; 2011 Apr; 3(4):1558-67. PubMed ID: 21283869
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of novel biodegradable methoxy poly(ethylene glycol)-zein micelles for effective delivery of curcumin.
Podaralla S; Averineni R; Alqahtani M; Perumal O
Mol Pharm; 2012 Sep; 9(9):2778-86. PubMed ID: 22770552
[TBL] [Abstract][Full Text] [Related]
15. A prodrug nanoassembly entrapping drugs as a tumor-targeted delivery system.
Yuan Z; Yi X; Zhang J; Cheng S; Zhuo R; Li F
Chem Commun (Camb); 2013 Jan; 49(8):801-3. PubMed ID: 23235958
[TBL] [Abstract][Full Text] [Related]
16. Preparation, characterisation and maintenance of drug efficacy of doxorubicin-loaded human serum albumin (HSA) nanoparticles.
Dreis S; Rothweiler F; Michaelis M; Cinatl J; Kreuter J; Langer K
Int J Pharm; 2007 Aug; 341(1-2):207-14. PubMed ID: 17478065
[TBL] [Abstract][Full Text] [Related]
17. beta-Cyclodextrin-curcumin self-assembly enhances curcumin delivery in prostate cancer cells.
Yallapu MM; Jaggi M; Chauhan SC
Colloids Surf B Biointerfaces; 2010 Aug; 79(1):113-25. PubMed ID: 20456930
[TBL] [Abstract][Full Text] [Related]
18. Increase of therapeutic activity of doxorubicin by long circulating liposomes in combination with curcumin.
Wang H; Hu L; Li C; Zhang J; Zhang T
Pharmazie; 2011 Nov; 66(11):871-4. PubMed ID: 22204133
[TBL] [Abstract][Full Text] [Related]
19. Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles.
Wang H; Zhao Y; Wu Y; Hu YL; Nan K; Nie G; Chen H
Biomaterials; 2011 Nov; 32(32):8281-90. PubMed ID: 21807411
[TBL] [Abstract][Full Text] [Related]
20. Targeting the extracellular matrix of ovarian cancer using functionalized, drug loaded lyophilisomes.
van der Steen SC; Raavé R; Langerak S; van Houdt L; van Duijnhoven SM; van Lith SA; Massuger LF; Daamen WF; Leenders WP; van Kuppevelt TH
Eur J Pharm Biopharm; 2017 Apr; 113():229-239. PubMed ID: 28034806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]